Document Detail


Percutaneous left atrial appendage closure for stroke prevention in patients with atrial fibrillation: an assessment of net clinical benefit.
MedLine Citation:
PMID:  23008509     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
AimsThe PROTECT-AF (WATCHMAN Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) trial found left atrial appendage (LAA) closure an alternative to anticoagulation in selected patients with non-valvular atrial fibrillation (AF). We aim to estimate the net clinical benefit (NCB) of percutaneous LAA closure.Methods and resultsPost hoc analysis of outcomes among 707 adults with AF in the PROTECT-AF trial and 566 in the Continued Access (CAP) registry undergoing LAA closure with the Watchman device compared with sustained anticoagulation. Outcomes were ischaemic stroke, intracranial haemorrhage, major bleeding, pericardial effusion, and death, weighted to reflect the relative impact in terms of death and disability. Net clinical benefit was calculated as the sum of annualized rates of these outcomes after intervention minus rates on warfarin. The NCB of LAA closure during 1623 person-years follow-up in the trial was 1.73%/year (95% CI: -0.54 to 4.39%/year) and during 741 patient-years in the registry was 4.97%/year (95% CI: 3.07-7.15%/year). Among patients with a history of ischaemic stroke, the NCB was greater in the registry (8.68%/year, CI: 2.82-14.92%/year) than the trial (4.30%/year, CI -2.07 to 11.25%/year). In the registry, the NCB of LAA closure increased from 2.22%/year (CI: 0.27-6.01%/year) in patients with CHADS(2) scores = 1 to 6.12%/year (CI: 3.19-8.92%/year) in those with scores ≥2.ConclusionCombining rates of thrombo-embolism, intracranial haemorrhage, major adverse events, and death allows objective comparison of the benefit and risk of device therapy vs. anticoagulation in patients with AF. The NCB of LAA closure is greatest for patients at a higher risk of stroke.
Authors:
Sandeep R Gangireddy; Jonathan L Halperin; Valentin Fuster; Vivek Y Reddy
Related Documents :
9022099 - Surgical removal of subfoveal choroidal neovascularization in presumed ocular histoplas...
19846059 - Long-term outcome of idiopathic macular hole surgery.
7800359 - Herpes zoster ophthalmicus in malawi.
18408499 - The treatment of branch retinal vein occlusion with bevacizumab.
9709749 - Treatment of reopened macular hole after vitrectomy by laser and outpatient fluid-gas e...
23355629 - Effects of angiotensin receptor blockade (arb) on mortality and cardiovascular outcomes...
23348639 - Ingestion of glutamine and maltodextrin two hours preoperatively improves insulin sensi...
23625389 - Early oral intake after total laryngectomy does not increase pharyngocutaneous fistuliz...
22124309 - Intracranial hemorrhage associated with vitamin k deficiency bleeding in biliary atresi...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-9-24
Journal Detail:
Title:  European heart journal     Volume:  -     ISSN:  1522-9645     ISO Abbreviation:  Eur. Heart J.     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-9-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8006263     Medline TA:  Eur Heart J     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Helmsley Electrophysiology Center, Mount Sinai School of Medicine, New York City, NY, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Predictors of functional decline in elderly patients undergoing transcatheter aortic valve implantat...
Next Document:  Endothelial cell repopulation after stenting determines in-stent neointima formation: effects of bar...